Polyglandular dysfunction, unspecified
ICD-10 E31.9 is a billable code used to indicate a diagnosis of polyglandular dysfunction, unspecified.
Polyglandular dysfunction refers to a condition where multiple endocrine glands fail to function properly, leading to a variety of hormonal imbalances. This dysfunction can manifest in various ways, including growth abnormalities, puberty disorders, and thymus disorders. In children and adolescents, polyglandular dysfunction may result in delayed or precocious puberty due to the disruption of the hypothalamic-pituitary-gonadal axis. Additionally, thymus disorders can lead to immune deficiencies, as the thymus plays a crucial role in T-cell maturation. Growth abnormalities may arise from insufficient hormone production, particularly growth hormone, thyroid hormones, and sex steroids. The unspecified nature of this code indicates that the specific glands involved or the exact nature of the dysfunction is not clearly defined, making it essential for healthcare providers to document clinical findings thoroughly to guide appropriate treatment and management.
Detailed hormonal assessment and gland function tests.
Patients presenting with unexplained growth delays or hormonal imbalances.
Ensure all relevant lab results and imaging studies are included in the documentation.
Growth charts, puberty assessment, and family history of endocrine disorders.
Children with delayed puberty or abnormal growth patterns.
Document developmental milestones and any psychosocial factors affecting growth.
Used to evaluate thyroid function in patients with suspected polyglandular dysfunction.
Document the reason for the test and any relevant clinical findings.
Endocrinologists should ensure comprehensive thyroid evaluations are included.
Common symptoms include growth abnormalities, delayed or precocious puberty, fatigue, weight changes, and recurrent infections due to immune dysfunction.
